Canada markets closed

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
85.84+0.75 (+0.88%)
At close: 04:00PM EDT
86.61 +0.77 (+0.90%)
After hours: 05:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 51.28B
Enterprise Value 50.28B
Trailing P/E 36.68
Forward P/E 30.96
PEG Ratio (5 yr expected) 3.42
Price/Sales (ttm)8.42
Price/Book (mrq)7.20
Enterprise Value/Revenue 8.18
Enterprise Value/EBITDA 28.42

Trading Information

Stock Price History

Beta (5Y Monthly) 1.07
52-Week Change 3-4.07%
S&P500 52-Week Change 325.77%
52 Week High 396.12
52 Week Low 360.57
50-Day Moving Average 389.87
200-Day Moving Average 378.43

Share Statistics

Avg Vol (3 month) 33.47M
Avg Vol (10 day) 33.01M
Shares Outstanding 5602.6M
Implied Shares Outstanding 6603.73M
Float 8596.62M
% Held by Insiders 10.88%
% Held by Institutions 184.11%
Shares Short (Apr 15, 2024) 47.38M
Short Ratio (Apr 15, 2024) 42.29
Short % of Float (Apr 15, 2024) 41.23%
Short % of Shares Outstanding (Apr 15, 2024) 41.22%
Shares Short (prior month Mar 15, 2024) 410.45M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 23:1
Last Split Date 3Jun 01, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 23.01%
Operating Margin (ttm)27.39%

Management Effectiveness

Return on Assets (ttm)12.05%
Return on Equity (ttm)21.28%

Income Statement

Revenue (ttm)6.14B
Revenue Per Share (ttm)10.15
Quarterly Revenue Growth (yoy)9.50%
Gross Profit (ttm)N/A
EBITDA 1.92B
Net Income Avi to Common (ttm)1.41B
Diluted EPS (ttm)2.32
Quarterly Earnings Growth (yoy)3.30%

Balance Sheet

Total Cash (mrq)1.7B
Total Cash Per Share (mrq)2.82
Total Debt (mrq)699.2M
Total Debt/Equity (mrq)9.73%
Current Ratio (mrq)3.76
Book Value Per Share (mrq)11.82

Cash Flow Statement

Operating Cash Flow (ttm)528.2M
Levered Free Cash Flow (ttm)671.94M